Long-term comparative study of Substance-P with methylprednisolone on the development of osteoporosis

Journal of Toxicological Sciences

Volumn 39, Issue 3, 2014, Pages 391-399

  Hong, Hyun Sook ^a   Um, Jihyun ^b   Lee, Zang Hee ^c   Son, Youngsook ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c BK 21 Plus   (South Korea)

Author keywords

Osteoporosis; Side effect; Steroids; Substance P

Indexed keywords

ALKALINE PHOSPHATASE; DEXAMETHASONE; METHYLPREDNISOLONE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY WEIGHT; BONE DENSITY; BONE MASS; COLLAGEN METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HISTOLOGY; LETTER; MALE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD GLUCOSE; BODY WEIGHT; BONE DENSITY; CELL MOVEMENT; COLLAGEN; DEXAMETHASONE; HUMANS; INJECTIONS; MALE; METHYLPREDNISOLONE; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; SUBSTANCE P; TIME FACTORS;

EID: 84901365548     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.39.391     Document Type: Article

References (38)

1. An, Y.S., Lee, E., Kang, M.H., Hong, H.S., Kim, M.R., Jang, W.S., Son, Y. and Yi, J.Y. (2011): Substance P stimulates the recovery of bone marrow after the irradiation. J. Cell. Physiol., 226, 1204-1213.
2. Angelopoulos, T.P., Tentolouris, N.K., Bertsias, G.K. and Boumpas, D.T. (2013): Steroid-induced diabetes in rheumatologic patients. Clin. Exp. Rheumatol., 32, 126-130.
3. Bost, K.L., Breeding, S.A.L. and Pascual, D.W. (1992): Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. Reg. Immunol., 4, 105-112.
4. Bronicki, R.A., Backer, C.L., Baden, H.P., Mavroudis, C., Crawford, S.E. and Green, T.P. (2000): Dexamethasone Reduces the Inflammatory Response to Cardiopulmonary Bypass in Children. Ann. Thorac. Surg., 69, 1490-1495.
5. Browner, W.S., Pressman, A.R. and Nevitt, M.C. (1996): Cummings SR Mortality following fractures in older women. The study of osteoporotic fractures. Arch. Intern. Med., 156, 1521-1525.
6. Budai, D. (2000): Neurotransmitters and receptors in the dorsal horn of the spinal cord. Acta Biologica Szegediensis, 44, 21-38.
7. Caliri, A., De Filippis, L., Bagnato, G.L. and Bagnato, G.F. (2007): Osteoporotic fractures: mortality and quality of life. Panminerva Med., 49, 21-27.
8. Datar, P., Srivastava, S., Coutinho, E. and Govil, G. (2004): "Substance P: structure, function, and therapeutics". Current Topics in Medicinal Chemistry, 4, 75-103.
9. Garnero, P., Darte, C. and Delmas, P.D. (1999): A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone, 24, 603-609.
10. Garnero, P. and Delmas, P.D. (1998): Clinical usefulness of markers of bone remodeling in osteoporosis. In: Meunier PJ, editor. Osteoporosis diagnosis and management. London: Martin Dumitz Ltd., 79-101.
11. Harrison, S. and Geppetti, P. (2001): "Substance-P". The International Journal of Biochemistry & Cell Biology, 33, 555-576.
12. Ho, W.Z., Lai, J.P. and Zhu, X.H. (1997): Uvaydova, M, Douglas, S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol., 159, 5654-5660.
13. Hong, H.S., Kim, D.Y., Yoon, K.J. and Son, Y. (2011): A new paradigm for stem cell therapy: substance-P as a stem cell-stimulating agent. Arch. Pharm. Res., 34, 2003-2006.
14. Hong, H.S., Lee, J., Lee, E., Kwon, Y.S., Lee, E., Ahn, W., Jiang, M.H., Kim, J.C. and Son, Y. (2009): A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat. Med., 15, 425-435.
15. Hong, H.S., Kim, D.Y., Lee, E.K. and Son, Y.S. (2009): A composition for preventing or treating inflammation. Kor. Patent 10-2009-0075881.
16. Hwang, J.L. and Weiss, R.E. (2013): Steroid-induced Diabetes: A clinical and molecular approach to understanding and treatment. Diabetes Metab Res. Rev. doi: 10.1002/dmrr.2486. [Epub ahead of print]
17. Jared, K., James, L.S., Lisa, S. Veena, F., Nandita, K., Jose, F.L., Pierre, N., Sergio, T., Roberta, H.A. and Jeff, B. (2013): Short Course Infliximab and Extracorporeal Photopheresis As Therapy For Steroid-Refractory Acute Gvhd In Matched Related and Unrelated Allogeneic Hematopoietic Cell Transplant (HCT). Blood, 122, 4590.
18. Jiang, M.H., Chung, E.K., Chi, G.F., Ahn, W.S., Lim, J.E., Hong H.S., Kim, D.W., Choi, H.W., Kim, J.Y. and Son, Y.S. (2012): Substance P induces M2-type macrophages after spinal cord injury. Neuroreport, 23, 786-792.
19. Jiang, M.H., Lim, J.E., Chi, G.F., Ahn, W.S., Zhang, M., Chung, E.K. and Son, Y.S. (2013): Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury. NeuroReport, 24, 846-851.
20. Kan, L., Lounev, V.Y., Pignolo, R.J., Duan, L., Liu, Y., Stock, S.R., McGuire, T.L., Lu, B., Gerard, N.P., Shore, E.M., Kaplan, F.S. and Kessler, J.A. (2011): Substance P signaling mediates BMP-dependent heterotopic ossification. J. Cell. Biochem., 112, 2759-2772.
21. Kang, M.H., Kim, D.Y., Yi, J.Y. and Son, Y.S. (2009): Substance P accelerates intestinal tissue regeneration after gamma-irradiation-induced damage. Wound Repair Regen., 17, 216-223.
22. Kim, D.Y., Hong, H.S. and Son, Y.S. (2010): Method for inhibiting or treating intestinal damage caused by radiotherapy or chemotherapy comprising administering substance-p. US 7846901B2.
23. Kress, B.C. (1998): Bone alkaline phosphatase: methods of quantitation and clinical utility. J. Clin. Ligand Assay, 21, 139-148.
24. Kress, B.C., Mizrahi, I.A., Armour, K.W., Marcus, R., Emkey, R.D. and Santora, A.C. 2nd (1999): Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin. Chem., 45, 1009-1017.
25. O'Connor, T.M., O'Connell, J., O'Brien, D.I., Goode, T., Bredin, C.P. and Shanahan, F. (2004): The role of Substance P in inflammatory disease. J. Cell. Physiol., 201, 167-180.
26. Price, C.P. (1993): Multiple forms of human serum alkaline phosphatase: detection and quantitation. Ann. Clin. Biochem., 30, 355-372.
27. Quartara, L. and Maggi, C.A. (1997): The tachykinin NK1 receptor: Part I: Ligands and mechanisms of cellular activation. Neuropeptides, 31, 537-563.
28. Rameshwar, P., Zhu, G., Donnelly, R.J., Qian, J., Ge, H., Goldstein, K.R., Denny, T.N. and Gascón, P. (2001): The dynamics of bone marrow stromal cells in the proliferation of multipotent hematopoietic progenitors by substance P: an understanding of the effects of a neurotransmitter on the differentiating hematopoietic stem cell. J. Neuroimmunol., 121, 22-31.
29. Rameshwar, P., Poddar, A. and Gascon, P. (1997): Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk. Lymphoma, 28, 1-10.
30. Rogers, A., Hannon, R.A. and Eastell, R. (2000): Biochemical markers as predictors of rates of bone loss after menopause. J. Bone Miner Res., 15, 1398-1404.
31. Ross, P.D. and Knowltin, W. (1998): Rapid bone loss is associated with increased levels of biochemical markers. J. Bone Miner Res., 13, 207-302.
32. Salisbury, E., Rodenberg, E., Sonnet, C., Hipp, J., Gannon, F.H., Vadakkan, T.J., Dickinson, M.E., Olmsted-Davis, E.A. and Davis, A.R. (2011): Sensory Nerve Induced Inflammation Contributes to Heterotopic Ossification. J. Cell. Biochem., 112, 2748-2758.
33. Spiegel, A., Shivtiel, S., Kalinkovich, A., Ludin, A., Netzer, N., Goichberg, P., Azaria, Y., Resnick, I., Hardan, I., Ben-Hur, H., Nagler, A., Rubinstein, M. and Lapidot, T. (2007): Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat. Immunol., 8, 1123-1131.
34. Spiegel, A., Zcharia, E., Vagima, Y., Itkin, T., Kalinkovich, A., Dar, A., Kollet, O., Netzer, N., Golan, K., Shafat, I., Ilan, N., Nagler, A., Vlodavsky, I. and Lapidot, T. (2008): Heparanase regulates retention and proliferation of primitive Sca-1+/c-Kit+/Lin-cells via modulation of the bone marrow microenvironment. Blood, 111, 4934-4943.
35. Wang, L., Zhao, R., Shi, X., Wei, T., Halloran, B.P., Clark, D.J., Jacobs, C.R. and Kingery, W.S. (2009): Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone, 45, 309-320.
36. Yamazaki, K. and Allen, T.D. (1990): Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: The "Neuro-Reticular Complex". Am. J. Anat., 187, 261-276.
37. Yang, C.M., Hsiao, L.D., Chien, C.S., Lin, C.C., Luo, S.F., Wang and C.C. (2002): Substance P-induced activation of p42/44 mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells., Cell. Signal, 14, 913-923.
38. Yoon, J.H., Kim, H.J., Kim, S.J., Yun, Y.S., Chun, J.I., Park, H.J. and Park, B.K. (2013): Early-onset Pericardial Effusion after Autologous Hematopoietic Stem Cell Transplantation in a Child with Neuroblastoma. Clin. Pediatr Hematol. Oncol., 20, 121-125.